- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03232775
Use of a Visual Pedagogy and Structure With Children With Autism for Routine Physical Exams
Evaluating the Effects of a Visual Pedagogy and Structure on the Successful Completion of the Medical Office Visit and Physical Examination With Pre-pubescent Children With Autism
Study Overview
Status
Conditions
Detailed Description
Objective: This pilot study aimed to evaluate the effects of a picture-schedule reinforcement system on reducing problem behaviors in children with Autism Spectrum Disorder (ASD) during a physical exam.
Design, setting, patients, intervention: Fifteen study participants, aged 5-10 years, with autism and identified by caregivers as typically uncooperative with physical exams were randomized to one of two physical exam groups (treatment and control) based on their adaptive communication score. The treatment group exam included use of a picture schedule-reinforcement book and the control group exam did not introduce the book. Caregivers rated participants' irritability/stereotypy behaviors before and during study exams. Exam teams blinded to study aims, recorded participants' total exam items completed and caregivers rated participants' level of cooperation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Chronological ages 4 to 10 years.
- Presumptive diagnosis of Autistic Disorder or Asperger's Disorder prior to study admission from a psychologist or psychiatrist experienced with children who have autism.
Meets research criteria for Autistic Spectrum Disorder:
- Meets cut-off scores for autism spectrum on the Social Communication Questionnaire (SCQ) (cut-off = 15) and
- Meets empirically-derived algorithm cut-off scores for Autism Spectrum Disorders on the Autism Diagnostic Observation Schedule (ADOS).
- All subjects will have the ADOS administered by a clinician trained in research reliability standards.
- The Principal Investigator, a certified ADOS trainer and research reliable, or trained designee under the supervision of the Principal Investigator, will administer the ADOS.
- Participants will represent the typical DSM-IV diagnostic developmental profile of children on the autism spectrum and no neurological injuries or illnesses before the age of three years that could account for their symptoms (i.e., meningitis, encephalitis, severe head injury or seizure disorder).
A Communication standard score ≤ 85, as measured by the Vineland Adaptive Behavior Scales - II.
a) The VABS-II will be administered by the Principal Investigator or trained designee under the supervision of the Principal Investigator as part of the initial phone screening process.
- Children with an ASD, particularly school-aged children and adolescents, may present with myriad prescribed psychotropic medications. Therefore, we will not exclude children on a variety of psychotropic medications; rather we will conduct a qualitative analysis to look at this issue.
- No restrictions regarding race or gender will be applied to the autism or developmental disability sample. Every effort will be made not to over-represent any particular race and/or gender group.
- Physically healthy prior to physical exam.
- Previous exposure to visual systems. This will be assessed based on caregiver report during the phone screening using one question relating to the use of visual structure with the child.
History of:
- Poor Cooperation
- Completely Uncooperative
Physical exams rated by caregiver on 4-point scale of cooperation modified from Forsberg et al. [56].
- 0 = No problems with cooperation;
- 1 = Minor problems with cooperation: Child shows mild behavior problems and/or anxiety symptoms;
- 2 = Poor cooperation: Child's behavior problems and/or anxiety symptoms requires that the medical staff have to spend extra time and effort to manage the child and complete the exam;
- 3 = Completely uncooperative: Exam is not possible due to child's behavior problems and/or anxiety symptoms
Exclusion Criteria:
- Participants with intelligence quotient standard scores > 40.
Presence of the following genetic or progressive neurological disorders known to be causative of or potentially resulting in a phenotype similar to autism:
- Fragile X,
- Landau Kleffner, Rett Disorder,
- Childhood Disintegrative Disorder, or
- Tuberous Sclerosis, based on screening by clinical staff and subsequent review by medical staff as needed
- Presence of vision or hearing loss or significant motor impairments.
- Wards of the State.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Treatment
Treatment: Physical Exam with Visual Pedagogy and Structure
|
Routine physical examination participants receive visual pedagogy and reinforcement (preferred food treat).
|
Other: Control
Control: Physical Exam without Visual Pedagogy and Structure
|
Participants engage in routine physical examination without visual pedagogy and reinforcement (preferred food treat).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline on the Aberrant Behavior Checklist-Community measure ( irritability and stereotypy subscales)
Time Frame: The end of the 15-minute waiting period and within 15 minutes after the completion of physical exam
|
Caregiver report form of subjects' behaviors.
|
The end of the 15-minute waiting period and within 15 minutes after the completion of physical exam
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of study exam items completed during study exams
Time Frame: Within 15 minutes after conclusion of each participant's study exam.
|
Study medical personnel teams (nurse and medical resident) tallied number of total exam items completed during study exams with each participant
|
Within 15 minutes after conclusion of each participant's study exam.
|
Change from baseline in Cooperation likert-scale rating form
Time Frame: At study entry and within 15 minutes after the completion of study physical exams
|
Caregiver report form of subjects' cooperation behaviors during study physical exams.
|
At study entry and within 15 minutes after the completion of study physical exams
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Robin Gabriels, PsyD, University of Colorado, Denver
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 07-0362
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hoffmann-La RocheActive, not recruitingAutism Spectrum Disorder (ASD)United States, Canada, Italy, Spain
-
Axial Therapeutics, Inc.Active, not recruitingAutism Spectrum Disorder (ASD)United States, Australia, New Zealand
-
Technion, Israel Institute of TechnologyCompleted
-
Stanford UniversityNational Institute on Deafness and Other Communication Disorders (NIDCD)CompletedAutism | Autism Spectrum Disorder (ASD)United States
-
Corporacion Parc TauliUnknown
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyTerminatedAutism Spectrum Disorder (ASD)Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
-
Florida Gulf Coast UniversityCompletedAutism Spectrum Disorder High-FunctioningUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
National Taiwan University HospitalCompletedAutism Spectrum Disorder High-FunctioningTaiwan
Clinical Trials on Treatment: Physical Exam with Visual Pedagogy and Structure
-
Riphah International UniversityCompleted
-
Mahidol UniversityThailand Research FundCompleted
-
Riphah International UniversityCompletedMedial Tibial Stress SyndromePakistan
-
Association Francaise pour la Recherche ThermaleFloralis; TIMC-IMAGRecruitingDiabetes Mellitus | Physical Activity | Therapeutic Education | Dietetic RulesFrance
-
University of ChicagoRecruitingCervical Cancer | Anal Cancer | HPV-Related Carcinoma | HPV-Related Cervical Carcinoma | Uterine Cervical Cancer | HPV-Related Anal Squamous Cell CarcinomaUnited States
-
Universidad Industrial de SantanderCompleted
-
Johns Hopkins Bloomberg School of Public HealthCompletedOpioid Use Disorder | Substance Use Disorders | Stigma, SocialUnited States
-
Federal University of São PauloCompleted
-
Hospital Universitario La PazRecruiting
-
Fondation Ophtalmologique Adolphe de RothschildBayerActive, not recruiting